Valuation: OneSource Specialty Pharma Limited

Market Cap 170B 1.78B 1.53B 1.43B 1.31B 2.47B 2.49B 16.9B 6.58B 85.81B 6.7B 6.55B 284B P/E 2026
-229x
P/E 2027 * 37.4x
Enterprise Value 181B 1.9B 1.63B 1.52B 1.39B 2.63B 2.65B 17.97B 7B 91.27B 7.12B 6.97B 302B EV / Sales 2026
12.7x
EV / Sales 2027 * 8.21x
Free-Float
64.51%
Yield 2026 *
-
Yield 2027 * -
1 day-2.14%
1 week-2.43%
Current month-8.40%
1 month-12.16%
3 months-17.83%
6 months+12.16%
Current year-18.06%
1 week 1,478
Extreme 1478
1,555.7
1 month 1,478
Extreme 1478
1,755.2
Current year 1,057
Extreme 1057
1,917.8
1 year 1,057
Extreme 1057
1,925
3 years 1,057
Extreme 1057
2,248
5 years 1,057
Extreme 1057
2,248
10 years 1,057
Extreme 1057
2,248
Manager TitleAgeSince
Chief Executive Officer 54 2024-02-29
Director of Finance/CFO - 2024-07-03
Compliance Officer - 2023-03-13
Director TitleAgeSince
Director/Board Member 65 2021-04-06
Director/Board Member 54 2024-02-29
Director/Board Member 66 2025-02-26
Change 5-day change 1-year change 3-year change Capi.($)
-2.14%-2.43%-20.31% - 1.82B
-0.96%+1.62%+1.80%+23.79% 51.65B
+0.10%-0.35%+473.87%+563.08% 45.31B
+0.64%+4.70%+39.00%+17.67% 42.7B
-0.59%-0.66%+21.19%+85.25% 42.79B
-2.27%-3.02%+14.22%+51.50% 32.87B
+0.44%+0.99%+30.90%+134.78% 17.14B
-0.82%-3.00% - - 16.61B
-1.70%+3.06%+11.11%+28.57% 15.01B
-0.06%+2.46%+81.49%+49.49% 14.21B
Average -0.78%+2.50%+72.59%+119.27% 28.01B
Weighted average by Cap. -0.59%+2.71%+100.26%+138.63%

Financials

2026 2027 *
Net sales 13.41B 141M 121M 113M 103M 195M 197M 1.33B 519M 6.77B 528M 517M 22.41B 21.8B 229M 196M 184M 168M 316M 320M 2.17B 843M 11B 859M 840M 36.42B
Net income -1.19B -12.49M -10.7M -10.03M -9.16M -17.28M -17.45M -118M -46.04M -601M -46.88M -45.86M -1.99B 4.46B 46.77M 40.08M 37.55M 34.3M 64.74M 65.38M 443M 172M 2.25B 176M 172M 7.45B
Net Debt 10.81B 113M 97.14M 91.02M 83.14M 157M 158M 1.07B 418M 5.45B 426M 416M 18.06B 8.86B 92.89M 79.6M 74.59M 68.13M 129M 130M 880M 342M 4.47B 349M 341M 14.8B
Logo OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited is an India-based vertically integrated biopharma service company with the capabilities to develop and manufacture complex biologics, biosimilars and vaccines. It operates as a specialty pharma pure-play contract development and manufacturing organization (CDMO). The Company specializes in prefilled syringes (with or without a safety device), dial and push variable and fixed dose pen injectors, pull push fixed dose pens and autoinjectors. Its integrated services offer comprehensive biologics solutions. It supports the development of complex biologics, including microbial and mammalian cell line biopharmaceuticals, cell and gene therapy and ribonucleic acid (RNA) products. The Company caters to a variety of capsule shapes and sizes, as well as formulations, traditional softgels to enteric coated capsules, vegan alternatives, chewable formats, vaginal pessaries, liposomal capsules, applicaps, and suppositories.
Employees
1,412
Date Price Change Volume
26-08-26 1,483.60 -2.14% 130,037
26-08-25 ₹1,516.10 -1.02% 60,036
26-08-24 ₹1,531.80 -0.21% 80,345
26-08-21 ₹1,535.00 +0.03% 50,188
26-08-20 ₹1,534.50 +0.92% 73,142
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1,483.60INR
Average target price
2,056.00INR
Spread / Average Target
+38.58%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ONESOURCE Stock